Products

Igovomab (TAB-043)

Recombinant antibody F(ab')2 fragment Fabto MUC16. Indium (111In) igovomab (trade name Indimacis-125) was a mouse monoclonal antibody for the diagnosis of ovarian cancer.
Linked to the chelating agent DTPA and labelled with Indium-111, it was used for imaging (radio-immuno scintigraphy) of the cancer. The drug is no longer available.      

  • Datasheet

Specifications
Immunogen
The details of the immunogen for this antibody are not available.
Host
Mouse
Derivation
Mouse
Type
F(ab')2 - G1
Specificity
Tested positive against native human antigen.
Species Reactivity
Human
Applications
Suitable for use in ELISA, FC, IP, FuncS, IF, Neut, IHC and most other immunological methods.
Trade name
indimacis-125
CAS NO.
171656-50-1
Generic Name
Igovomab
Related Disease
Ovarian cancers
Target
Alternative Names
Igovomab; indimacis-125; 171656-50-1; Indimacis-125; Indium (111In) igovomab; MUC16; mucin 16, cell surface associated; mucin-16
Entrez Gene ID
94025
UniProt ID
Q8WXI7

For lab research use only, not for diagnostic, therapeutic or any in vivo human use.

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
Send Inquiry Now!
Name:
* Phone:
* E-mail Address:
* Service & Products Interested:
Project Description:
* Verification Code:
Please input "biolabs"(case insensitive) as verification code.
Contact Us to Order
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Increase Efficiency to Accelerate Your Research & Discovery Process

Increase Efficiency to Accelerate Your Research & 
Discovery Process

Creative Biolabs is the leading custom service provider that has extensive experience in various antibody production and engineering fields. Our service portfolio includes mouse and rat monoclonal antibody production ...

Find out more >

USA

45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356

Europe

Tel: 44-207-097-1828
Email:
Follow us on:
           

Terms of Service-Privacy Policy     © 2007 - 2019 Creative-Biolabs All Rights Reserved